ESPA
logov3

Description

Doctor’s Formulas Co Q10 100mg Liposomal Formula 225ml

Food Supplement for Greater Absorption & Bioavailability of Active Substances & Vitamins
CO Q10 100mg is a food supplement that contains Coenzyme Q10 as ubiquinone.

Liposomal formulation technology results in greater absorption and bioavailability of active substances and vitamins.

Liposomes present several advantages when it comes to delivering vitamins and nutritional supplements:

protect the active substance from oxidation and degradation in the acidic pH of the stomach

increase absorption and bioavailability compared to free and other conventional pharmaceutical carriers (ie tablets, suspensions and capsules).

Liposomes

Liposomes belong to the colloidal dispersions of bioactive molecule transport systems that have the ability to transport them, improving their effectiveness. The dimensions of liposomes depending on the method of their preparation and the physicochemical characteristics of their structural units are of the order of nanometers up to the order of a few micrometers.

Historically, in the early 1960s, there was a tendency to study the biophysical properties of colloidal systems that had a lipid and phospholipid composition, with the aim of understanding the biophysical functions of cells. The biophysicist A.D. Bangham studied lipid colloidal dispersions to simulate cell membranes and study their functionality.

Liposomes, since they are prepared from structural materials like those of our cells, have advantages related to the ‘friendliness’ of human tissues. They have the ability to transport lipophilic bioactive molecules which do not dissolve easily in aqueous media and therefore have absorption and bioavailability problems, e.g. vitamins, curcumin, etc. but also water-soluble or amphiphilic molecules, improve in terms of their dissolution rate and absorption through the gastrointestinal tract.

Liposomes can and do transport bioactive substances and improve their penetration through the barriers of the gastrointestinal tract and are effective ‘vehicles’ for the transport of bioactive molecules.

Liposomal technology and especially the innovative technology of supramolecular phospholipid complexes with a lipid bilayer structure can improve the therapeutic efficacy of nutritional supplements and are an innovation in this field, giving high added value to the final dosage form.

 

E.O.F. Notification Number: 50526 /31-05-2017

(The Notification Number to the E.O.F. does not take the place of a marketing authorization from the E.O.F.)